NDC 55154-3563-00 - Levothyroxine Sodium
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 55154-3563
- Requested NDC
- 55154-3563-00
- Package NDCs from labels
- 55154-3563-0, 55154-3563-00
- Manufacturer
- Cardinal Health 107, LLC
- Effective date
- 2026-09-18
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Levothyroxine Sodium - Cardinal Health 107, LLC | Cardinal Health 107, LLC | 2026-09-18 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 55154-3563-0 | Levothyroxine Sodium | 10 in 1 BAG | TABLET | 10 | 8 | |
| 55154-3563-0 | Levothyroxine Sodium | 1 in 1 BLISTER PACK | TABLET | 1 | 8 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 55154-3563 | LEVOTHYROXINE SODIUM TABLET [CARDINAL HEALTH 107, LLC] | 6 | Current NDC, Legacy NDC, 2 package rows | 20240906_31a31756-68aa-4e01-bbb1-9d181f8d9181.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sodium Bicarbonate | SODIUM BICARBONATE | Exela Pharma Sciences, LLC | f8806ec3-a1c0-47a9-9660-2628dca4623e | 2026-08-25 | Warnings, Adverse reactions | 8MDF5V39QO |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | NorthStar RxLLC | 58f4dc90-3648-49dc-a7e1-baf918a773b5 | 2026-08-20 | Boxed warning, Warnings, Adverse reactions | 966248 966222 892246 966221 966224 966249 966220 966225 966253 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | NuCare Pharmaceuticals, Inc. | 597ea445-d926-adc6-e063-6394a90a6446 | 2026-08-20 | Boxed warning, Warnings, Adverse reactions | ANDA209713 966222 9J765S329G |
| omeprazole and sodium bicarbonate | OMEPRAZOLE, SODIUM BICARBONATE | Amazon.com Services LLC | bb453f26-c7df-4cce-8793-337cb5d5f9a9 | 2026-08-19 | Warnings | 8MDF5V39QO |
| sodium bicarbonate | SODIUM BICARBONATE | Baxter Healthcare Corporation | b50c858a-00c8-4cb2-ad73-8797f19e656d | 2026-08-14 | Warnings, Adverse reactions | 8MDF5V39QO |
| Sodium Bicarbonate | SODIUM BICARBONATE | Milla Pharmaceuticals Inc. | 2d2035c2-e41b-4d57-a23c-fae16ad9a355 | 2026-08-07 | Warnings, Adverse reactions | 8MDF5V39QO |
| Sodium Bicarbonate 5 gr | SODIUM BICARBONATE | TWIN MED LLC | e325d899-d9a6-5adb-e053-2995a90ac861 | 2026-08-04 | Warnings | 8MDF5V39QO |
| DERMFREE INSECT BITE RELIEF | SODIUM BICARBONATE 5% INSECT BITE RELIEF | Wenzhou Yuyuan Pharmaceutical Co., Ltd. | 5794886c-0d74-9f35-e063-6394a90a27d8 | 2026-07-27 | Warnings | 8MDF5V39QO |
| PEG 3350 and Electrolytes | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | A-S Medication Solutions | 19daf830-7270-4661-81b1-ded38f867f28 | 2026-07-24 | Warnings, Adverse reactions | 8MDF5V39QO |
| Quality Choice Effervescent Antacid and Pain Relief | ASPIRIN, ANHYDROUS CITRIC ACID, SODIUM BICARBONATE | Chain Drug Marketing Association, INC. | 56474a81-6e10-6c67-e063-6294a90a28c5 | 2026-07-10 | Warnings | 8MDF5V39QO |
| Sodium Bicarbonate | SODIUM BICARBONATE | Amneal Pharmaceuticals Private Limited | ac91e834-e693-43a2-829b-56793453e8cc | 2026-07-09 | Warnings, Adverse reactions | 8MDF5V39QO |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Coupler LLC | 55f4c679-86cb-b97f-e063-6294a90ad5ef | 2026-07-06 | Boxed warning, Warnings, Adverse reactions | ANDA209713 966221 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Coupler LLC | 55f67831-4680-edbf-e063-6294a90a1d36 | 2026-07-06 | Boxed warning, Warnings, Adverse reactions | ANDA209713 9J765S329G |
| SODIUM BICARBONATE | SODIUM BICARBONATE | HF Acquisition Co LLC, DBA HealthFirst | 9ee46a5b-d00e-4254-e053-2995a90aeb3a | 2026-06-29 | Warnings, Adverse reactions | 8MDF5V39QO |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Bryant Ranch Prepack | 489ffba8-983e-478f-8f62-fe08bf3d0e0b | 2026-06-23 | Boxed warning, Warnings, Adverse reactions | 966224 9J765S329G |
| SODIUM BICARBONATE | SODIUM BICARBONATE | HF Acquisition Co LLC, DBA HealthFirst | d8516f38-6f92-32d1-e053-2995a90a96bf | 2026-06-19 | Warnings, Adverse reactions | 8MDF5V39QO |
| Sodium Bicarbonate | SODIUM BICARBONATE, INJECTION | Civica, Inc. | 3737e5e5-2296-4a3d-b8f1-dfea1eff1927 | 2026-06-15 | Warnings, Adverse reactions | 8MDF5V39QO |
| E-Z-GAS II | ANTACID/ANTIFLATULENT | E-Z-EM, INC. | 4e12e1cb-b033-076d-e054-00144ff8d46c | 2026-06-15 | Warnings | 8MDF5V39QO |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | Coupler LLC | 544d67eb-8487-cb5d-e063-6394a90a3110 | 2026-06-15 | Boxed warning, Warnings, Adverse reactions | ANDA209713 9J765S329G |
| Sodium Bicarbonate | SODIUM BICARBONATE | Cardinal Health 107, LLC | 60c2a176-8854-4479-b853-d07fe9a1830c | 2026-06-12 | Warnings | 8MDF5V39QO |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.